miR-29c Increases Protein Synthesis in Skeletal Muscle Independently of AKT/mTOR

Paula Ketilly Nascimento Alves1, André Cruz1, William J Silva1

  • 1Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-900, Brazil.

Insights

MicroRNA-29c (miR-29c) enhances skeletal muscle growth and function by increasing fiber size and force. This occurs through elevated protein synthesis despite AKT/mTOR pathway downregulation.

Area of Science:

  • Molecular Biology
  • Muscle Physiology
  • Gene Regulation

Background:

  • microRNAs (miRNAs) are key regulators of gene expression, impacting cellular processes.
  • Skeletal muscle mass regulation is complex and involves fine-tuning by miRNAs.
  • Understanding miRNA roles is crucial for muscle adaptation and health.

Purpose of the Study:

  • To investigate the effect of miR-29c overexpression on skeletal muscle mass and function.
  • To elucidate the molecular mechanisms underlying miR-29c-mediated skeletal muscle adaptations.
  • To explore the interplay between miR-29c, protein synthesis, and the AKT/mTOR pathway.

Main Methods:

  • Skeletal muscle-specific overexpression of miR-29c using electrotransfer.
  • Assessment of muscle fiber size and force production.
  • Analysis of AKT/mTOR pathway components and overall protein synthesis rates.

Main Results:

  • miR-29c overexpression led to increased skeletal muscle fiber size and force at 7 and 30 days post-electrotransfer.
  • AKT/mTOR pathway components were downregulated following miR-29c electrotransfer.
  • Overall protein synthesis was significantly elevated at day 7, normalizing by day 30.

Conclusions:

  • miR-29c induces skeletal muscle hypertrophy and functional gains.
  • These effects are associated with increased protein synthesis, independent of AKT/mTOR pathway activation.
  • miR-29c represents a potential therapeutic target for muscle-related disorders.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K